Measuring the impact of MS on walking ability
The 12-Item MS Walking Scale (MSWS-12)
Abstract
Objective: To develop a patient-based measure of walking ability in MS.
Methods: Twelve items describing the impact of MS on walking (12-Item MS Walking Scale [MSWS-12]) were generated from 30 patient interviews, expert opinion, and literature review. Preliminary psychometric evaluation (data quality, scaling assumptions, acceptability, reliability, validity) was undertaken in the data generated by 602 people from the MS Society membership database. Further psychometric evaluation (including comprehensive validity assessment, responsiveness, and relative efficiency) was conducted in two hospital-based samples: people with primary progressive MS (PPMS; n = 78) and people with relapses admitted for IV steroid treatment (n = 54).
Results: In all samples, missing data were low (≤3.8%), item test–retest reproducibility was high (≥0.78), scaling assumptions were satisfied, and reliability was high (≥0.94). Correlations between the MSWS-12 and other scales were consistent with a priori hypotheses. The MSWS-12 (relative efficiency = 1.0) was more responsive than the Functional Assessment of Multiple Sclerosis mobility scale (0.72), the 36-Item Short Form Health Survey physical functioning scale (0.33), the Expanded Disability Status Scale (0.03), the 25-ft Timed Walk Test (0.44), and Guy’s Neurologic Disability Scale lower limb disability item (0.10).
Conclusions: The MSWS-12 satisfies standard criteria as a reliable and valid patient-based measure of the impact of MS on walking. In these samples, the MSWS-12 was more responsive than other walking-based scales.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Martin J, Meltzer M, Elliot D. OPCS surveys of disability in Great Britain. Report 1: the prevalence of disability among adults. London: Her Majesty’s Stationary Office, 1988.
2.
Chiou IL, Burnett CN. Values of activities of daily living: a survey of stroke patients and their home therapists. Arch Phys Med Rehabil . 1985; 65: 901–906.
3.
Swingler R, Compston DAS. The morbidity of multiple sclerosis. Q J Med . 1992; 83: 325–337.
4.
Hobart JC, Lamping DL, Fitzpatrick R, Riazi A, Thompson AJ. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain . 2001; 124: 962–973.
5.
Wade DT. Measurement in neurological rehabilitation. Oxford: Oxford University Press, 1992.
6.
Hauser SL, Dawson DM, Lehrich JR, et al. Intensive immunosuppression in progressive multiple sclerosis: a randomized three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med . 1983; 308: 173–180.
7.
Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology . 1983; 33: 1444–1452.
8.
Confavreux C, Compston DAS, Hommes OR, McDonald WI, Thompson AJ. EDMUS, a European database for multiple sclerosis. J Neurol Neurosurg Psychiatry . 1992; 55: 671–676.
9.
Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey manual and interpretation guide. Boston: Nimrod Press, 1993.
10.
Cella DF, Dineen K, Arnason B, et al. Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument. Neurology . 1996; 47: 129–139.
11.
Sharrack B, Hughes RAC. The Guy’s Neurological Disability Scale (GNDS). a new disability measure for multiple sclerosis. Mult Scler . 1999; 5: 223–233.
12.
Singh A, Crockard HA. Quantitative assessment of cervical spondylotic myelopathy by a simple walking test. Lancet . 1999; 354: 370–373.
13.
Hobart JC, Freeman JA, Thompson AJ. Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain . 2000; 123: 1027–1040.
14.
Hobart JC, Freeman JA, Lamping DL, Fitzpatrick R, Thompson AJ. The SF-36 in multiple sclerosis (MS): why basic assumptions must be tested. J Neurol Neurosurg Psychiatry . 2001; 71: 363–370.
15.
Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill, 1994.
16.
McHorney CA, Ware JE Jr, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patient groups. Med Care . 1994; 32: 40–66.
17.
Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep . 1966; 19: 3–11.
18.
Likert RA. A technique for the development of attitudes. Arch Psychol . 1932; 140: 5–55.
19.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika . 1951; 16: 297–334.
20.
Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull . 1955; 52: 281–302.
21.
Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care . 1989; 27: S178–S189.
22.
Liang MH, Fossel AH, Larson MG. Comparisons of five health status instruments for orthopedic evaluation. Med Care . 1990; 28: 632–638.
23.
Liang MH, Larson MG, Cullen KE, Schwartz JA. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum . 1985; 28: 542–547.
24.
Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials . 1991; 12: 142S–158S.
25.
McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res . 1995; 4: 293–307.
26.
Sprangers MAG, Aaronson NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: a review. J Clin Epidemiol . 1992; 45: 743–760.
27.
Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients don’t agree: cross sectional study of patients’ and doctors’ perceptions and assessments of disability in multiple sclerosis. Br Med J . 1997; 314: 1580–1583.
28.
Stewart AL, Hays RD, Ware JE. The MOS Short-Form General Health Survey. Reliability and validity in a patient population. Med Care . 1988; 26: 724–735.
29.
Hobart JC, Lamping DL, Freeman JA, et al. Evidence-based measurement: which disability scale for neurological rehabilitation? Neurology . 2001; 57: 639–644.
30.
Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press, 1960.
31.
Lord FM, Novick MR. Statistical theories of mental test scores. Reading, MA: Addison-Wesley, 1968.
32.
Rudick R, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol . 1997; 42: 379–382.
Information & Authors
Information
Published In
Copyright
© 2003.
Publication History
Received: January 24, 2002
Accepted: September 12, 2002
Published online: January 14, 2003
Published in print: January 14, 2003
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Microstructural Damage and Repair in the Spinal Cord of Patients With Early Multiple Sclerosis and Association With Disability at 5 Years, Neurology Neuroimmunology & Neuroinflammation, 12, 1, (2025)./doi/10.1212/NXI.0000000000200333
- Variability of Multiple Sclerosis Walking Scale and Multiple Sclerosis Impact Scale Scores in People Without Multiple Sclerosis, Cureus, (2024).https://doi.org/10.7759/cureus.51811
- Performance Measures and Plasma Biomarker Levels in Patients with Multiple Sclerosis after 14 Days of Fampridine Treatment: An Explorative Study, International Journal of Molecular Sciences, 25, 3, (1592), (2024).https://doi.org/10.3390/ijms25031592
- Feasibility of a new intervention addressing group-based balance and high-intensity training, physical activity, and employment in individuals with multiple sclerosis: a pilot randomized controlled trial, Frontiers in Rehabilitation Sciences, 4, (2024).https://doi.org/10.3389/fresc.2023.1258737
- The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event, Frontiers in Neurology, 15, (2024).https://doi.org/10.3389/fneur.2024.1407257
- Effectiveness of repeated injections of botulinum toxin A on gait and fatigue in adults with spastic paraparesis secondary to multiple sclerosis, NeuroRehabilitation, 54, 4, (663-675), (2024).https://doi.org/10.3233/NRE-240038
- Multipl Skleroz Hastalarında Denge ve Yürüyüş Değerlendirmelerinin Hasta Hedefleri ile İlişkisinin İncelenmesi, Ergoterapi ve Rehabilitasyon Dergisi, (105-110), (2024).https://doi.org/10.30720/ered.1470391
- Perceived and physiological strains of societal participation in people with multiple sclerosis: a real-time assessment study, Journal of Rehabilitation Medicine, 56, (jrm40838), (2024).https://doi.org/10.2340/jrm.v56.40838
- Effect of an interactive Pilates-based telerehabilitation intervention in people with multiple sclerosis: Protocol for a Randomized Controlled Trial. (Preprint), JMIR Research Protocols, (2024).https://doi.org/10.2196/58026
- Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial, PLOS ONE, 19, 2, (e0297235), (2024).https://doi.org/10.1371/journal.pone.0297235
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.